May 2010 - HAI Europe supports an EU inquiry into the handling of the A/H1N1 Influenza pandemic. Read the open letter.
HAI Europe represents the public health perspective on medicines issues by participating in formal consultations at the national, EU, and global levels; through membership in high-level EU platforms; and by supporting the participation of independent citizen voices in policy debates.
31 August 2011
HAI Europe and MIEF Response to HMA/EMA Guidance document on the identification of Commercially Confidential Information and the Protection of Personal Data within the Marketing Authorisation Structure Dossier
01 July 2011
HAI Europe Consultation Response to the European Medical Agency on ethical and GCP aspects of clinical trials in third countries